SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

NGL Fine-Chem - Quaterly Results

28 Oct 2022 Evaluate
Net sales declined -17.25%  to  Rs. 649.53 million from Rs. 784.97 millions.Net Profit of the company move down -65.02% to Rs. 49.64  millions from Rs. 141.89 millions  in the same quarter last year.The Operating Profit of the company witnessed a decrease to 88.50 millions from 214.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 649.53 784.97 -17.25 1278.90 1544.06 -17.17 3186.67 2552.07 24.87
Other Income 40.99 48.87 -16.12 77.46 98.09 -21.03 126.40 115.21 9.71
PBIDT 88.50 214.34 -58.71 119.73 494.83 -75.80 782.09 852.30 -8.24
Interest 1.20 4.02 -70.15 6.18 7.72 -19.95 15.62 18.40 -15.11
PBDT 87.30 210.32 -58.49 113.55 487.11 -76.69 766.47 833.90 -8.09
Depreciation 20.19 19.56 3.22 39.77 38.89 2.26 76.73 73.94 3.77
PBT 67.11 190.76 -64.82 73.78 448.22 -83.54 689.74 759.96 -9.24
TAX 17.47 48.87 -64.25 19.02 112.84 -83.14 167.28 205.28 -18.51
Deferred Tax 1.62 4.87 -66.74 -5.58 8.84 -163.12 -4.22 14.58 -128.94
PAT 49.64 141.89 -65.02 54.76 335.38 -83.67 522.46 554.68 -5.81
Equity 30.89 30.89 0.00 30.89 30.89 0.00 30.89 30.89 0.00
PBIDTM(%) 13.63 27.31 -50.10 9.36 32.05 -70.79 24.54 33.40 -26.51

NGL Fine-Chem Share Price

2229.75 -25.30 (-1.12%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×